North America AREDS 2 Supplements Market Size, Share & Trends Analysis Report By Product (Capsules, Tablets, Soft Gels), By Distribution Channel, By Country, And Segment Forecasts, 2024 - 2030

Market Size & Trends

The North America AREDS 2 supplements market size was estimated at USD 280.2 million in 2023 and is expected to grow at a CAGR of 6.1% from 2024 to 2030. The market is driven by the increasing prevalence of age-related macular degeneration (AMD) among the aging population. As the population ages, the incidence of eye-related conditions, particularly AMD, rises significantly. This has led to a growing awareness about eye health and the benefits of preventive measures, such as the use of AREDS 2 supplements, which have been clinically proven to reduce the risk of progression to advanced AMD. The demographic trend towards an older population, combined with heightened health consciousness, has spurred demand for these supplements.

In addition, as people become more educated about the importance of maintaining good eye health, they are actively seeking supplements that are formulated to support ocular wellness. Based on the Age-Related Eye Disease Study 2 conducted by the National Eye Institute, AREDS 2 supplements have gained popularity due to their specific formulation designed to reduce the risk of developing advanced age-related macular degeneration. These supplements typically contain a combination of antioxidants such as vitamins C and E, zinc, copper, lutein, and zeaxanthin, all of which have been shown to play a role in maintaining eye health and reducing the progression of certain eye conditions.

Market Concentration & Characteristics

The North America AREDS 2 supplements market shows moderate innovation, focusing on enhanced formulations with added nutrients such as lutein, zeaxanthin, and omega-3s to better protect against AMD. Innovations also include new delivery methods such as gummies and liquids to improve consumer compliance. Overall, the market sees steady, incremental advancements.

Companies focus on strategic acquisitions to expand their presence overseas and reinforce their position in the market. Over the next few years, internationally reputed companies are likely to acquire small medium-size companies operating in the industry in a bid to facilitate regional expansion.

Regulations in North America significantly impact the AREDS 2 supplements market by ensuring product safety, efficacy, and labeling accuracy. These regulations, enforced by bodies suh as the FDA in the U.S. and Health Canada in Canada, require rigorous testing and compliance with manufacturing standards. This oversight helps maintain consumer trust and market integrity but also increases production costs and time to market for manufacturers. Compliance with these stringent regulations ensures that AREDS 2 supplements are safe and effective for preventing age-related macular degeneration, fostering consumer confidence and potentially driving market growth.

In the North American market for AREDS 2 supplements, product substitutes include a variety of alternatives aimed at promoting eye health. These substitutes encompass general multivitamins with high levels of antioxidants and zinc, as well as specialized eye health supplements containing lutein and zeaxanthin.

The North America AREDS 2 supplements market shows a high degree of concentration among end users. This concentration is primarily driven by a few key demographic groups: older adults aged 50 and above, particularly those at higher risk of age-related macular degeneration (AMD). These individuals typically seek out AREDS 2 supplements due to their proven benefits in supporting eye health and preventing AMD progression.

Product Insights

North America AREDS 2 soft gels market accounted for a share of over 49% of the North Americas revenues in 2023. Soft gels are particularly popular among older adults due to their ease of swallowing and digestibility compared to traditional tablets or powders. Moreover, these formats often provide enhanced bioavailability, ensuring that the body absorbs the essential nutrients.

In response to the increasing demand for AREDS 2 supplements in soft gel format, key companies are innovating and expanding their product lines to better cater to consumer preferences. In June 2023, Bausch + Lomb launched PreserVision AREDS 2 Formula Soft Gels Plus CoQ10 in the U.S. It uniquely combines AREDS 2 nutrient formula with Coenzyme Q10 (CoQ10) to support both eye and heart health.

North America AREDS 2 capsules market is projected to grow at a CAGR of 6.2% from 2024 to 2030. As the population ages, the prevalence of age-related macular degeneration (AMD) increases, driving more individuals to seek preventive and therapeutic options, such as AREDS 2 supplements. The capsule format, in particular, appeals to consumers for its ease of use, precise dosing, and ability to mask unpleasant tastes and odors associated with certain ingredients like zinc.

Distribution Channel Insights

The sales of North America AREDS 2 supplements through pharmacies accounted for a share of around 51% of the North America revenues in 2023. It is experiencing notable growth as the aging population prefer prescribed eye health supplements from retinal specialists. According to a November 2022 study published in National Library of Medicine, a significant proportion of patients, particularly those recruited from single retinal clinics in the U.S. rely on recommendations from their retinal specialists when it comes to supplement intake.

The sales of North America AREDS 2 supplements through online distribution channels are projected to grow at a CAGR of 6.9% from 2024 to 2030. The market is driven by the convenience of online shopping, which allows consumers to easily compare products, read reviews, and purchase from the comfort of their homes.

E-commerce platforms such as Amazon and Walmart.com provide extensive selections and competitive pricing, enhancing accessibility. For instance, Amazon offers a wide array of AREDS 2 supplements from brands like Nature Made and Bausch + Lomb, often with customer reviews and ratings that aid in decision-making.

Country Insights

North America AREDS 2 Supplements Market The AREDS 2 supplements market in the North America is projected to grow at a CAGR of 6.1% from 2024 to 2030. The market for AREDS 2 (Age-Related Eye Disease Study 2) supplements in North America is primarily driven by the increasing prevalence of age-related eye diseases, particularly age-related macular degeneration (AMD). As the population ages, there is a corresponding rise in the incidence of AMD, which is a leading cause of vision loss in older adults. AREDS 2 supplements are specifically formulated with a combination of vitamins and minerals, such as vitamin C, vitamin E, zinc, copper, and lutein/zeaxanthin, which have been clinically shown to slow the progression of AMD and reduce the risk of vision loss in individuals already diagnosed with the condition.

U.S. AREDS 2 Supplements Market Trends

The AREDS 2 supplements market in the U.S. is projected to grow at a CAGR of 6.3% from 2024 to 2030. The rise in the elderly population in the U.S. contributes to the demand for AREDS 2 supplements. With advancements in healthcare and improved longevity, more individuals are reaching older ages, where the risk of AMD becomes more prevalent. As a result, there is a larger demographic seeking solutions to maintain eye health and potentially prevent or slow the progression of AMD. According to the Population Reference Bureau, in 2022, the elderly population (ages 65 and older) in the U.S. was 58 million, accounting for 17% of the total population. This elderly population is projected to increase to 82 million by 2050, a 47% rise.

Canada AREDS 2 Supplements Market Trends

The AREDS 2 supplements market in the Canada accounted for a share of over 11% of the North America revenues in 2023. The demand for AREDS 2 supplements in Canada is influenced by the high prevalence of AMD in the country. AMD is a leading cause of irreversible vision loss in the elderly, and oxidative stress is believed to be a contributing factor.

Mexico AREDS 2 Supplements Market Trends

The AREDS 2 supplements market in the Canada is projected to grow at a CAGR of 4.8% from 2024 to 2030. The demand for AREDS 2 supplements is fueled by the increasing number of people diagnosed with intermediate AMD, which can progress to late AMD if left untreated. The supplements are seen as a valuable tool in slowing down vision loss and improving eye health, especially for those who have already developed late AMD in one eye and are looking to prevent progression in the other eye.

Key North America AREDS 2 Supplements Company Insights

The market for North America AREDS 2 supplements is highly competitive, with a range of companies offering various products. Many big players are increasing their focus on new product launches, partnerships, and expansion into new markets to compete effectively.

Recent Developments

• In May 2024, EyePromise, a leading nutraceutical company specializing in eye health, unveiled the latest enhancements to its extensive nutritional program tailored for eyecare practices. Focused on innovation and enhancement, EyePromise has enhanced its AREDS 2-based products. These scientifically backed formulas will now be branded as Macular Health and Macular Health Complete.

• In February 2024, Codeage announced its latest retail partnership with Erewhon, a renowned leader in health and wellness retail. This collaboration highlights Codeage's dedication to providing advanced formulations and high-quality nutritional products to health-conscious consumers.

• In June 2023, Bausch + Lomb, a prominent global company focused on enhancing eye health for improved living, introduced PreserVision AREDS 2 Formula soft gels with added coenzyme Q10 (CoQ10) in the U.S. These soft gels provide a convenient two-in-one solution, combining the precise nutrient formula endorsed by the National Eye Institute (NEI) to mitigate the risk of moderate to advanced Age-related Macular Degeneration (AMD) progression in AMD patients.

North America AREDS 2 Supplements Market Report Scope

North America AREDS 2 Supplements Market Report Segmentation

This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the North America AREDS 2 supplements market report on the basis of product, distribution channel, and countries:

• Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Capsules

  • Tablets

  • Soft gels

  • Others

• Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

  • Pharmacies

  • Online

  • Others

• Country Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico